Free Trial

Aurinia Pharmaceuticals (AUPH) Insider Trading & Ownership

→ Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad)
Free AUPH Stock Alerts
$4.91
+0.04 (+0.82%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Aurinia Pharmaceuticals (NASDAQ:AUPH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$101,211.34
Get AUPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aurinia Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AUPH Insider Buying and Selling by Quarter

Ad Weiss Ratings
The Next Step of Their Control Is Here …
Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.
4 simple steps to protect your privacy and money before it’s too late.

Aurinia Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/23/2023David R.W. JayneDirectorSell8,733$11.26$98,333.58  
5/19/2023Joseph P HaganDirectorSell272$10.58$2,877.76  
(Data available from 1/1/2013 forward)

AUPH Insider Trading Activity - Frequently Asked Questions

Who is on Aurinia Pharmaceuticals's Insider Roster?

The list of insiders at Aurinia Pharmaceuticals includes David R.W. Jayne, George M Milne Jr, Jill Leversage, Joseph M Miller, Joseph P Hagan, Matthew Maxwell Donley, Michael Robert Martin, Neil Solomons, Peter Greenleaf, Robert Bindert Huizinga, and Stephen P Robertson. Learn more on insiders at AUPH.

What percentage of Aurinia Pharmaceuticals stock is owned by insiders?

4.30% of Aurinia Pharmaceuticals stock is owned by insiders. Learn more on AUPH's insider holdings.

Which Aurinia Pharmaceuticals insiders have been buying company stock?

The following insider purchased AUPH shares in the last 24 months: George M Milne Jr ($178,200.00).

How much insider buying is happening at Aurinia Pharmaceuticals?

Insiders have purchased a total of 20,000 AUPH shares in the last 24 months for a total of $178,200.00 bought.

Which Aurinia Pharmaceuticals insiders have been selling company stock?

The following insiders have sold AUPH shares in the last 24 months: David R.W. Jayne ($98,333.58), Joseph M Miller ($100,986.24), Joseph P Hagan ($2,877.76), Peter Greenleaf ($292,785.00), and Stephen P Robertson ($173,453.88).

How much insider selling is happening at Aurinia Pharmaceuticals?

Insiders have sold a total of 72,453 Aurinia Pharmaceuticals shares in the last 24 months for a total of $668,436.46 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:AUPH) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
These AI trades triggered this morning (545% return)
Prosper Trading Academy
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
Banyan Hill Publishing
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Fed launches fourth dollar overhaul
Stansberry Research
Man Who Predicted 2008: “This Will be Worse.”
Altimetry